Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer

Radiographics

Volumn 31, Issue 3, 2011, Pages 771-789

  Larici, Anna Rita ^a   del Ciello, Annemilia ^a   Maggi, Fabio ^a   Santoro, Silvia Immacolata ^a   Meduri, Bruno ^a   Valentini, Vincenzo ^a   Giordano, Alessandro ^a   Bonomo, Lorenzo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; LUNG INJURY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; MINIMAL RESIDUAL DISEASE; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION INJURY; RADIOGRAPHY; SCINTISCANNING; TUMOR RECURRENCE;

CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG INJURY; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RADIATION INJURIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79958051536     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.313105096     Document Type: Article

References (44)

1. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999;17(9):2692-2699.
2. Rosenzweig KE, Amols H, Ling CC. New radiotherapy technologies. Semin Surg Oncol 2003;21 (3):190-195.
3. Dosoretz DE, Katin MJ, Blitzer PH, et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992;24(1):3-9.
4. PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2005(2):CD002142.
5. Komaki R, Cox JD, Hartz AJ, et al. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. Am J Clin Oncol 1985;8(5): 362-370.
6. Fairchild A, Harris K, Barnes E, et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 2008;26(24):4001-4011.
7. Emami B. Three-dimensional conformal radiation therapy in bronchogenic carcinoma. Semin Radiat Oncol 1996;6(2):92-97.
8. Koenig TR, Munden RF, Erasmus JJ, et al. Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 2002;178(6):1383-1388.
9. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45(2): 323-329.
10. Haasbeek CJ, Slotman BJ, Senan S. Radiotherapy for lung cancer: clinical impact of recent technical advances. Lung Cancer 2009;64(1):1-8.
11. Trovo M, Linda A, El Naqa I, Javidan-Nejad C, Bradley J. Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 2010;69(1):77-85.
12. Ball D. Stereotactic radiotherapy for nonsmall cell lung cancer. Curr Opin Pulm Med 2008;14(4): 297-302.
13. Park HJ, Kim KJ, Park SH, Kay CS, Oh JS. Early CT findings of tomotherapy-induced radiation pneumonitis after treatment of lung malignancy. AJR Am J Roentgenol 2009;193(3):W209-W213.
14. Park KJ, Chung JY, Chun MS, Suh JH. Radiationinduced lung disease and the impact of radiation methods on imaging features. RadioGraphics 2000; 20(1):83-98.
15. Choi YW, Munden RF, Erasmus JJ, et al. Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radio Graphics 2004; 24(4):985-997; discussion 998.
16. Takeda T, Takeda A, Kunieda E, et al. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT. AJR Am J Roentgenol 2004;182(5):1123-1128.
17. Linda A, Trovo M, Bradley JD. Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. Eur J Radiol 2009; Nov 30. [Epub ahead of print]
18. Armstrong J, McGibney C. The impact of three-dimensional radiation on the treatment of non-small cell lung cancer. Radiother Oncol 2000;56(2): 157-167.
19. Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 2010;94(1):1-11.
20. Davis SD, Yankelevitz DF, Henschke CI. Radiation effects on the lung: clinical features, pathology, and imaging findings. AJR Am J Roentgenol 1992;159 (6):1157-1164.
21. Rodrigues G, Lock M, D'Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer: a systematic review. Radiother Oncol 2004;71(2):127-138.
22. López Rodríguez M, Cerezo Padellano L. Toxicity associated to radiotherapy treatment in lung cancer patients. Clin Transl Oncol 2007;9(8):506-512.
23. Aoki T, Nagata Y, Negoro Y, et al. Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. Radiology 2004;230(1):101-108.
24. Libshitz HI, Southard ME. Complications of radiation therapy: the thorax. Semin Roentgenol 1974; 9(1):41-49.
25. Libshitz HI. Radiation changes in the lung. Semin Roentgenol 1993;28(4):303-320.
26. Libshitz HI, DuBrow RA, Loyer EM, Charnsangavej C. Radiation change in normal organs: an overview of body imaging. Eur Radiol 1996;6(6): 786-795.
27. Libshitz HI, Shuman LS. Radiation-induced pulmonary change: CT findings. J Comput Assist Tomogr 1984;8(1):15-19.
28. Ikezoe J, Morimoto S, Takashima S, Takeuchi N, Arisawa J, Kozuka T. Acute radiation-induced pulmonary injury: computed tomography evaluation. Semin Ultrasound CT MR 1990;11(5):409-416.
29. Ikezoe J, Takashima S, Morimoto S, et al. CT appearance of acute radiation-induced injury in the lung. AJR Am J Roentgenol 1988;150(4):765-770.
30. Tada T, Minakuchi K, Matsui K, Kawase I, Fukuda H, Nakajima T. Radiation pneumonitis following multi-field radiation therapy. Radiat Med 2000;18 (1):59-61.
31. Im JG, Itoh H, Shim YS, et al. Pulmonary tuberculosis: CT findings-early active disease and sequential change with antituberculous therapy. Radiology 1993;186(3):653-660.
32. Salinas FV, Winterbauer RH. Radiation pneumonitis: a mimic of infectious pneumonitis. Semin Respir Infect 1995;10(3):143-153.
33. Webb WR, Müller N, Naidich DP. High-resolution CT of the lung. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2001; 260-266.
34. Hung JJ, Hsu WH, Hsieh CC, et al. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009; 64(3):192-196.
35. Bourgouin P, Cousineau G, Lemire P, Delvecchio P, Hébert G. Differentiation of radiation-induced fibrosis from recurrent pulmonary neoplasm by CT. Can Assoc Radiol J 1987;38(1):23-26.
36. Libshitz HI, Sheppard DG. Filling in of radiation therapy-induced bronchiectatic change: a reliable sign of locally recurrent lung cancer. Radiology 1999;210(1):25-27.
37. Takeda A, Kunieda E, Takeda T, et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2008;70(4):1057-1065.
38. Trott KR. Second cancers after radiation therapy. In: Joiner M, van der Kogel A, eds. Basic clinical radiobiology. 4th ed. London, England: Hodder Arnold, 2009; 339-351.
39. Takigawa N, Kiura K, Segawa Y, et al. Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. Br J Cancer 2006;95(9):1142-1144.
40. Kostakoglu L, Agress H Jr, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. RadioGraphics 2003;23(2):315-340.
41. Erasmus JJ, McAdams HP, Patz EF Jr, Goodman PC, Coleman RE. Thoracic FDG PET: state of the art. RadioGraphics 1998;18(1):5-20.
42. Kim EE, Chung SK, Haynie TP, et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. RadioGraphics 1992;12(2):269-279.
43. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995;36(5):788-793.
44. Bury T, Corhay JL, Duysinx B, et al. Value of FDGPET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999;14(6):1376-1380.